Asamuddin, Sitti Amena S.
HRN: 21-48-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
CEFTRIAXONE 1G (VIAL)
05/29/2022
06/04/2022
IVT
1.5gm
OD
WBC 13.6, T/C Blood Dyscrasia
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes